Clinical trial
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC…
NCT00232219 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00232219 |
|---|---|
| Title | Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion |
| Official title | Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion. |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Fish oil |
| Enrollment | 200 |
| Start date | Jan 1, 2003 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Oct 4, 2005 |
| Last update posted | May 5, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: